Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.
Interest in Chaga mushroom supplements is surging across 2025 wellness trends, as consumers seek cleaner, science-aligned alternatives for immune support, inflammation balance, and energy recovery. With dual-extracted fruiting body sourcing and lab-tested transparency, Pilly Labs’ latest formula is gaining attention as a serious contender in the adaptogenic mushroom space—without the hype or filler.
MENDOTA HEIGHTS, Minn., Aug. 1, 2025 /PRNewswire/ -- St. Croix Hospice and Mayo Clinic Health System (MCHS) have entered into a definitive agreement for St. Croix...
Jarrard Inc. promotes new partner and welcomes six new team members
NASHVILLE, Tenn., Aug. 1, 2025 /PRNewswire/ -- Jarrard Inc., a U.S. Top 10 healthcare...
Pickleball designed by Life Time Founder, Chairman and CEO, Bahram Akradi and his engineering team with consistent bounce and durability in mind; Ball available...
Strategic acquisition strengthens Clinisys's leadership in laboratory informatics across the full spectrum of healthcare, life sciences, and public health.
BANGALORE, India and TUCSON, Ariz., Aug. 1,...
SEOUL, South Korea, Aug. 1, 2025 /PRNewswire/ -- Medit (www.medit.com), a global leader in digital dentistry, today introduces the Medit i900 Mobility, a next-generation intraoral scanner...
MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its...
TORONTO, July 31, 2025 /CNW/ - Bayshore HealthCare (Bayshore) is proud to announce its Integrated Care Solutions (ICS) division has achieved Accredited with Commendation...
- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million, resulting in a cumulative increase in carrying value of assets held for sale by approximately $2.7 million - - No change to 2024 or first quarter 2025 Adj. EBITDA -
ALAMEDA, Calif., July 30, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord...
WILLIAMSBURG, Va., July 30, 2025 /PRNewswire/ -- The Conference of Chief Justices (CCJ) and Conference of State Court Administrators (COSCA) today released the findings of...
MOBILE, Ala., July 29, 2025 /PRNewswire/ -- AltaPointe Health is excited to announce the opening of its newest children's outpatient clinic located at 4211...
CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave™ Ultrasound Imaging SystemThe VxWave Ultrasound Imaging System potentially provides important insights...